Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


The information that direct healthcare professional communications offer us

  • At: Seville (Spain) (2022)
  • Type: Poster
  • Poster code: HMI-031
  • By: MARIñO, Eduardo L. ()
  • Co-author(s): Ms Ana G. Mariño, Clinical Pharmacy and Pharmaceutical Care Unit (University of Barcelona, Barcelona, Spain)
    Mr Marcos Gallego (Hospital Sagrat Cor, Barcelona, Spain)
    Dr Cecilia F. Lastra (University of Barcelona, Barcelona, Spain)
    Dr Pilar Modamio (University of Barcelona, Barcelona, Spain)
    Prof Eduardo L. Mariño (University of Barcelona, Barcelona, Spain)
    Ms Cecilia Mariño, Clinical Pharmacy and Pharmaceutical Care Unit (University of Barcelona, Barcelona, Spain)
  • Abstract:

    Background information:
    Drugs are subjected, before they are marketed, to a series of non-clinical and clinical studies that will define for a therapeutic indication how to use them correctly. However, these studies have limited nature, which means that is essential to subject medicines to post-marketing control and surveillance,..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses